[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,552,513
  • Shares Outstanding, K 45,446
  • Annual Sales, $ 1,334 M
  • Annual Income, $ 97,310 K
  • EBIT $ 285 M
  • EBITDA $ 403 M
  • 60-Month Beta 0.52
  • Price/Sales 2.65
  • Price/Cash Flow 10.36
  • Price/Book 4.58

Options Overview Details

View History
  • Implied Volatility 64.51% (+3.61%)
  • Historical Volatility 37.01%
  • IV Percentile 95%
  • IV Rank 84.15%
  • IV High 72.27% on 10/21/25
  • IV Low 23.32% on 03/17/26
  • Expected Move (DTE 31) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 37
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 2,535
  • Open Int (30-Day) 5,313
  • Expected Range 78.17 to 78.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.07
  • Number of Estimates 6
  • High Estimate $1.13
  • Low Estimate $1.02
  • Prior Year $1.10
  • Growth Rate Est. (year over year) -2.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.81 +8.20%
on 07/09/26
80.00 -2.88%
on 07/16/26
+3.53 (+4.76%)
since 06/18/26
3-Month
51.00 +52.35%
on 05/08/26
81.99 -5.23%
on 06/11/26
+17.49 (+29.05%)
since 04/21/26
52-Week
47.31 +64.22%
on 09/26/25
87.32 -11.02%
on 12/10/25
+3.93 (+5.33%)
since 07/21/25

Most Recent Stories

More News
1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm

1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm

BOH : 83.83 (+0.04%)
ASTE : 54.71 (+1.52%)
HAE : 77.80 (-0.47%)
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026

BOSTON , July 8, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2027 financial results at 6:00 am ET on Thursday,...

HAE : 77.80 (-0.47%)
3 Reasons HAE is Risky and 1 Stock to Buy Instead

3 Reasons HAE is Risky and 1 Stock to Buy Instead

HAE : 77.80 (-0.47%)
3 Profitable Stocks We Find Risky

3 Profitable Stocks We Find Risky

HRL : 25.20 (-0.32%)
WCN : 168.65 (-1.30%)
HAE : 77.80 (-0.47%)
Haemonetics Updates Financial Reporting Segments

BOSTON , June 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today...

HAE : 77.80 (-0.47%)
Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference

BOSTON , June 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 47th...

HAE : 77.80 (-0.47%)
Haemonetics (HAE) Stock Is Up, What You Need To Know

Haemonetics (HAE) Stock Is Up, What You Need To Know

HAE : 77.80 (-0.47%)
Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)

Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)

HAE : 77.80 (-0.47%)
3 Russell 2000 Stocks That Concern Us

3 Russell 2000 Stocks That Concern Us

WERN : 46.30 (-0.02%)
HAE : 77.80 (-0.47%)
RDN : 39.03 (+0.41%)
3 Small-Cap Stocks We’re Skeptical Of

3 Small-Cap Stocks We’re Skeptical Of

LUCK : 7.25 (-2.16%)
FCF : 20.88 (-0.10%)
HAE : 77.80 (-0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 81.28
2nd Resistance Point 80.42
1st Resistance Point 79.30
Last Price 77.80
1st Support Level 77.32
2nd Support Level 76.46
3rd Support Level 75.34

See More

52-Week High 87.32
Last Price 77.80
Fibonacci 61.8% 72.04
Fibonacci 50% 67.32
Fibonacci 38.2% 62.60
52-Week Low 47.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.